Bright Health Group(BHG) - 2023 Q3 - Quarterly Report

Discontinued Operations - Total revenue from discontinued operations for the nine months ended September 30, 2023, was $1,384,116, with premium revenue of $1,319,292 [141]. - Operating loss from discontinued operations for the nine months ended September 30, 2023, was $(238,310) [141]. - Cash used in operating activities for discontinued operations was $(2,310,771) for the nine months ended September 30, 2023 [144]. - Total assets of discontinued operations as of September 30, 2023, amounted to $1,368,694 [144]. - Total liabilities of discontinued operations as of September 30, 2023, were $974,502 [144]. - The company reported a net loss from discontinued operations of $(240,321) for the nine months ended September 30, 2023 [141]. Company Strategy and Focus - The company has focused on its value-driven Consumer Care business, NeueHealth, to improve quality and cost of care [140]. - The company announced restructuring charges totaling $10,080 for the nine months ended September 30, 2023, as part of its strategic changes [150]. Financial Obligations - The company has entered into repayment agreements with CMS for an aggregate amount of $380 million, due in 18 months from September 15, 2023 [159]. Care Delivery Segment - As of September 30, 2023, the Care Delivery segment serves approximately 330,000 consumers through 72 owned primary care clinics [139].